Malignant neoplasm of left renal pelvis
ICD-10 C65.2 is a billable code used to indicate a diagnosis of malignant neoplasm of left renal pelvis.
C65.2 refers to a malignant neoplasm located in the left renal pelvis, which is the area of the kidney where urine collects before it moves to the ureter. This type of cancer is classified under urinary tract malignancies and is often associated with risk factors such as smoking, exposure to certain chemicals, and chronic irritation or inflammation of the urinary tract. Symptoms may include hematuria (blood in urine), flank pain, and urinary obstruction. Diagnosis typically involves imaging studies such as CT scans or MRIs, and confirmation is achieved through biopsy. Staging of renal pelvis cancer is crucial for determining the treatment approach and prognosis, with stages ranging from localized tumors to advanced disease that may have metastasized to lymph nodes or distant organs. Surgical management often involves nephroureterectomy, which is the removal of the affected kidney and ureter, and may be accompanied by lymph node dissection. Adjuvant therapies, including chemotherapy or immunotherapy, may also be considered based on the tumor's characteristics and stage.
Detailed surgical notes, pathology reports, and imaging studies must be documented to support the diagnosis and treatment plan.
Urologists frequently encounter patients with hematuria, flank pain, or incidental findings on imaging that lead to further evaluation for renal pelvis tumors.
Urologists should ensure that all relevant clinical findings and treatment decisions are clearly documented to support coding and billing.
Oncologists must provide comprehensive treatment plans, including chemotherapy regimens and follow-up care details.
Oncologists often manage patients post-surgery for renal pelvis cancer, focusing on adjuvant therapies and monitoring for recurrence.
Accurate documentation of tumor characteristics and response to treatment is essential for coding and reimbursement.
Used for surgical management of left renal pelvis malignancy.
Operative report detailing the procedure and findings.
Urologists should document the extent of the surgery and any complications.
Common symptoms include hematuria, flank pain, and urinary obstruction. Patients may also experience weight loss and fatigue.
